Publisher's Synopsis
TO 340B, OR NOT TO 340B: THAT IS THE QUESTION offers an essential, in-depth guide to understanding the 340B Drug Pricing Program-one of the most impactful yet misunderstood programs in healthcare today. Written by a pharmacist and attorney with firsthand experience in the 340B space, this book is designed for newcomers and professionals alike who want to navigate the complexities of the program and its operational strategies.
Through real-world case studies, data-driven insights, and expert commentary, this book provides a comprehensive overview of the program's history, its critical role in providing affordable care to underserved populations, and actionable strategies to maximize its benefits. Whether you're a healthcare executive, compliance officer, policy maker, pharmacy manager, provider, community advocate, or someone new to the world of 340B, this book provides the essential knowledge to optimize the 340B program in your organization.
Inside you will learn:
The history and evolution of the 340B Drug Pricing Program and its key legal and operational frameworks.
Proven strategies for optimizing 340B management, maximizing savings, and ensuring compliance.
Real-world success stories of how 340B has been leveraged to improve healthcare access, reduce costs, and enhance patient outcomes.
The future of 340B, including emerging trends, challenges, and advocacy strategies to protect and preserve the program.
This book is not just about compliance-it's about empowering safety-net providers to stretch every dollar and deliver better care to low-income, uninsured, and underinsured patients. If you're involved in or interested in the 340B program, this comprehensive guide will equip you with the tools, insights, and confidence needed to navigate the complexities of the program, advocate for its sustainability, and ensure that it continues to make a real difference in the lives of vulnerable populations.
